Poland· PL-100056428

Szyszka Chmielu

A medicinal product containing lupuli flos, registered in Poland by Zakład Zielarski "Kawon-Hurt" Nowak Sp.J..

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedSzyszka ChmieluATC—REGISTER NO.PL-100056428PACKS LISTED1CHECKEDSeptember 27, 2026

The record

At a glance

URPL (Poland)
Active substance
Lupuli flos
Manufacturer
Zakład Zielarski "Kawon-Hurt" Nowak Sp.J.
Country
Poland (PL)
ATC code
—
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 1

  • gtin
    05909990218912

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Lupuli flos in 2 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All lupuli flos products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ba6dfe73-b854-44b5-820a-9096657a3ed2
GET /v1/drugs/ba6dfe73-b854-44b5-820a-9096657a3ed2?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Zioło pojedyncze",
  "source": "urpl",
  "strength": "-",
  "packaging": "05909990218912 ¦ OTC ¦ 8446\n1 op. 25 g",
  "substance": "Lupuli strobilus + Lupuli flos -",
  "common_name": "Lupuli flos",
  "pl_product_id": "100056428",
  "pozwolenie_nr": "02189",
  "auth_procedure": "NAR",
  "authorisation_validity": "2025-02-25"
}

See everything about lupuli flos.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.